within Pharmacolibrary.Drugs.ATC.G;

model G01AA10_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 10.2 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 600 / 1000000,
    adminCount     = 1,
    Vd             = 0.0008,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Clindamycin is a broad-spectrum lincosamide antibiotic, effective against Gram-positive cocci and anaerobic bacteria. Approved and used in treatment of infections such as MRSA, dental infections, and pelvic inflammatory disease.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics after intravenous administration in healthy adults (single 600 mg IV dose).</p><h4>References</h4><ol><li><p>Watson, MK, et al., &amp; Chinnadurai, SK (2017). Pharmacokinetics of intravenous clindamycin phosphate in captive Bennett&#x27;s wallabies (Macropus rufogriseus). <i>Journal of veterinary pharmacology and therapeutics</i> 40(6) 682–686. DOI:<a href=&quot;https://doi.org/10.1111/jvp.12421&quot;>10.1111/jvp.12421</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28568310/&quot;>https://pubmed.ncbi.nlm.nih.gov/28568310</a></p></li><li><p>Sullins, AK, &amp; Abdel-Rahman, SM (2013). Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. <i>Paediatric drugs</i> 15(2) 93–117. DOI:<a href=&quot;https://doi.org/10.1007/s40272-013-0017-5&quot;>10.1007/s40272-013-0017-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23529866/&quot;>https://pubmed.ncbi.nlm.nih.gov/23529866</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G01AA10_1;
